Novartis Pharma unveils preventive measures against misconduct

Novartis Pharma unveils preventive measures against misconduct

Dirk Kosche, president of Novartis Pharma K.K., the Japanese unit of Swiss pharmaceutical maker Novartis AG, bows in apology during a press conference in Tokyo on June 9, 2015. Kosche unveiled measures to prevent the reoccurrence of company misconduct involving not reporting serious side effects of its drugs. (Kyodo) ==Kyodo

  • Product Code
  • ILEA000070829
  • Registered date
  • 2015/6/09 18:38:56
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • Media size
  • 2437 × 3163 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 496.71(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Konica Minolta to buy U.S. drug research company for 32 bil. yen

    Konica Minolta to buy U.S. drug research company for 32 bil. yen

    Konica Minolta Inc. President Shoei Yamana speaks at a press conference in Tokyo on Sept. 25, 2017. The Japanese maker of copiers, printers and precision equipment will acquire U.S. pharmaceutical research company Invicro LLC for roughly 32 billion yen ($284 million) in a bid to enhance its medical-related operations. (Kyodo) ==Kyodo
      Japan generic drug maker Nichi-Iko to acquire Sagent of U.S.

      Japan generic drug maker Nichi-Iko to acquire Sagent of U.S.

      Yuichi Tamura, president of generic drug company Nichi-Iko Pharmaceutical Co., has a press conference in Toyama, Japan, on July 11, 2016. Nichi-Iko will acquire U.S. generic drug maker Sagent Pharmaceuticals Inc. for roughly $736 million in a bid to expand its presence in the U.S. market. (Kyodo) ==Kyodo